The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivityRebecca Newton, Donald Ogilvie, Amanda Lyons et al.|European Journal of Medicinal Chemistry|2016Cited by 40
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascadeAmanda J. Watson, Donald Ogilvie, Gemma V. Hopkins et al.|F1000Research|2016Cited by 6
Identification of selective inhibitors of RET and comparison with current clinical candidates through development and validation of a robust screening cascadeAmanda J. Watson, Donald Ogilvie, Gemma V. Hopkins et al.|F1000Research|2016Cited by 6
Abstract C39: First-in-class inhibitors of the putatively undruggable DNA repair target Poly(ADP-ribose) glycohydrolase (PARG)Bohdan Waszkowycz, Donald Ogilvie, Dominic I. James et al.|Molecular Cancer Therapeutics|2015Cited by 0
Abstract 778: The identification and structure-guided optimisation of potent and selective inhibitors of oncogenes in medullary thyroid carcinoma and lung adenocarcinomaRoger J. Butlin, Donald Ogilvie, Rebecca Newton et al.|Cancer Research|2015Cited by 0